1. Home
  2. SCKT vs CVKD Comparison

SCKT vs CVKD Comparison

Compare SCKT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCKT
  • CVKD
  • Stock Information
  • Founded
  • SCKT 1992
  • CVKD 2022
  • Country
  • SCKT United States
  • CVKD United States
  • Employees
  • SCKT N/A
  • CVKD N/A
  • Industry
  • SCKT Computer Manufacturing
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • SCKT Technology
  • CVKD Health Care
  • Exchange
  • SCKT Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • SCKT 8.4M
  • CVKD 8.2M
  • IPO Year
  • SCKT 1995
  • CVKD 2023
  • Fundamental
  • Price
  • SCKT $1.18
  • CVKD $0.45
  • Analyst Decision
  • SCKT
  • CVKD Strong Buy
  • Analyst Count
  • SCKT 0
  • CVKD 2
  • Target Price
  • SCKT N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • SCKT 7.4K
  • CVKD 72.2K
  • Earning Date
  • SCKT 07-31-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • SCKT N/A
  • CVKD N/A
  • EPS Growth
  • SCKT N/A
  • CVKD N/A
  • EPS
  • SCKT N/A
  • CVKD N/A
  • Revenue
  • SCKT $17,699,212.00
  • CVKD N/A
  • Revenue This Year
  • SCKT $10.78
  • CVKD N/A
  • Revenue Next Year
  • SCKT $8.00
  • CVKD N/A
  • P/E Ratio
  • SCKT N/A
  • CVKD N/A
  • Revenue Growth
  • SCKT N/A
  • CVKD N/A
  • 52 Week Low
  • SCKT $0.90
  • CVKD $0.36
  • 52 Week High
  • SCKT $1.59
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • SCKT 57.04
  • CVKD 48.55
  • Support Level
  • SCKT $1.11
  • CVKD $0.43
  • Resistance Level
  • SCKT $1.20
  • CVKD $0.49
  • Average True Range (ATR)
  • SCKT 0.06
  • CVKD 0.02
  • MACD
  • SCKT 0.01
  • CVKD -0.00
  • Stochastic Oscillator
  • SCKT 85.71
  • CVKD 39.47

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: